ArticleFrontiers in cognition2026
Transdiagnostic and clinical predictors of longitudinal misophonia symptoms.
Article in Frontiers in cognition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Anxiety sensitivity (AS) and distress tolerance (DT) are emotional-vulnerability factors driving emotion dysregulation. AS and DT may amplify misophonia. Research examining transdiagnostic factors predicting misophonia is largely cross-sectional. We examined relations between AS, DT, and longitudinal misophonia symptoms, adjusting for clinical variables. Methods: Fifty-eight individuals recruited from soQuiet endorsing clinical misophonia symptoms completed baseline and daily surveys 3x daily for 30 days. Results: Bivariate analyses suggested baseline AS was associated with elevated longitudinal misophonia symptoms during and not during triggers, while baseline DT was associated with higher misophonia symptoms during triggers. Baseline AS, momentary emotion dysregulation, and baseline misophonia were predictors of longitudinal misophonia during triggers, adjusting for momentary emotion dysregulation, baseline misophonia, and baseline obsessions and compulsions. An alpha correction suggested an attenuated AS effect. Null effects for DT may be explained by analyses supporting emotion dysregulation as a mediator of the relation between DT and misophonia. Effects of obsessive-compulsive symptoms were null. Discussion: Results inform longitudinal relations between transdiagnostic factors and misophonia. A predominant limitation is sample homogeneity. Misophonia symptom fluctuations appear contextualized, likely impacted by environmental and emotional-vulnerability factors. Results inform ongoing advancements to misophonia assessment and, pending further investigation, clinical interventions targeting malleable transdiagnostic factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.